OPTIRAY 300 (300 mg l/ml), solution for injection in a vial 10 bottles of 100 ml
Active ingredients: Iodine, Ioversol
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection10 bottles of 100 mlintraartérielle;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OPTIRAY 300 (300 mg l/mL), solution injectable en flacon
- Pharmaceutical form
- solution injectable
- Route of administration
- intraartérielle;intraveineuse
- Presentation description
- 10 flacon(s) en verre de 100 ml
- Marketing authorisation holder
- GUERBET
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Dec 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67722465CIP75601632CIP133400956016327Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IODEsolution | 30,0 g · 100 ml | FT |
| IOVERSOLsolution | 63,6 g · 100 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.